Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00801320 · ClinicalTrials.gov registry record · NA
Primary Tumor Harvest for the Purpose of Possible Use in a Future Clinical Trial in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer
A NA study, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT00801320 is a NA study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 100 participants.
The verdict
NCT00801320, a NA study, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The purpose of this research study is to collect tumor samples at the time of surgery and store them for possible use as part of an experimental vaccine study for the participants cancer in the future.
Interventions
- PROCEDURE Tumor collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2008-09 |
| Est. Completion | 2020-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00801320
The ClinicalTrials.gov registry entry for NCT00801320 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tumor collection is the first listed.
NCT00801320 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00801320 about?
NCT00801320 is a clinical study titled "Primary Tumor Harvest for the Purpose of Possible Use in a Future Clinical Trial in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer". The purpose of this research study is to collect tumor samples at the time of surgery and store them for possible use as part of an experimental vaccine study for the participants cancer in the future.
What is the current status of trial NCT00801320?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2008-09. Estimated completion is 2020-08.
What interventions are being tested in trial NCT00801320?
The interventions under investigation include: Tumor collection (PROCEDURE).
Who is sponsoring clinical trial NCT00801320?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.